As drug discovery becomes more complex, companies must innovate to stay ahead. https://ow.ly/JIKt50SxnJ7 Norstella is using AI to help biopharma professionals better understand challenges and guide decisions to improve pipeline to patient decision-making.
Norstella’s Post
More Relevant Posts
-
Great to spend some time with Kris Kaneta and Suzanne Caruso to talk about Norstella's next generation of AI-enabled pharma intelligence tools. We're all well aware of the pain points - expensive R&D, high attrition rates, inaccurate forecasting, and patchy coverage for drugs once approved. Norstella is looking forward to being part of the solution, allowing our clients to make the best possible decisions as they progress their innovation from pipeline to patient. This ebook is a short summary of how we see the industry challenges, and the imperative to adopt AI and our philosophy in doing so, and what Norstella is cooking up. Please take a look - it's only a short read. And if you'd like to learn any further about our work, or take part in early adopter programs, do get in touch!
As drug discovery becomes more complex, companies must innovate to stay ahead. https://ow.ly/JIKt50SxnJ7 Norstella is using AI to help biopharma professionals better understand challenges and guide decisions to improve pipeline to patient decision-making.
-
-
As drug discovery becomes more complex, companies must innovate to stay ahead. https://ow.ly/YMhK30sEVNA Norstella is using AI to help biopharma professionals better understand challenges and guide decisions to improve pipeline to patient decision-making.
-
-
Want to know how AI is being used in the biopharma world, this is an interested read for all my financial markets contacts. As drug discovery becomes more complex, companies must innovate to stay ahead. https://ow.ly/JIKt50SxnJ7 Norstella is using AI to help biopharma professionals better understand challenges and guide decisions to improve pipeline to patient decision-making.
-
This year's #PharmaMESBerlin sessions sparked many engaging and insightful discussions. It's great to see Hernan Vilas, a key contributor to our program, in his element talking about #Digitaltransformation and #AI. "It's clear that we are only beginning to scratch the surface, and deepening our comprehension of AI as a disruptive technology will pave the way for smoother adoption."
Challenge Your Peers: AI for the Pharma Shop Floor; the future of efficiency and quality Today's #PharmaMESBerlin session sparked an engaging and insightful discussion. A big thank you to all those who joined us to explore and unleash the full potential of AI/ML in pharmaceutical manufacturing. Together with Philipp Kläsle, we navigated through the significant challenges and exciting opportunities presented by both classical AI and Generative AI. It's clear that we're only beginning to scratch the surface, and deepening our comprehension of AI as a disruptive technology will pave the way for smoother adoption. The future is full of possibilities, and I'm thrilled to be on this journey. #AIinPharma #DigitalTransformation #AI
-
-
In this paper we examine the expanding role of #AI in the #biopharma industry. While AI has been widely used in research and development, there is still room for increased integration in downstream commercial operations. Read more to understand how AI biopharma companies will continue to grow and play a pivotal role in enhancing existing capabilities and bolstering pipeline activities. #lifesciences #KPMGHCLS #KPMGDeals
AI and its expanding role across the biopharma landscape
-
Procurement & Supply Chain Lead | Delivering streamlined processes through automated end-to-end solutions
In this paper we examine the expanding role of #AI in the #biopharma industry. While AI has been widely used in research and development, there is still room for increased integration in downstream commercial operations. Read more to understand how AI biopharma companies will continue to grow and play a pivotal role in enhancing existing capabilities and bolstering pipeline activities. #lifesciences #KPMGHCLS #KPMGDeals
AI and its expanding role across the biopharma landscape
kpmg.voicestorm.com
-
In this paper we examine the expanding role of #AI in the #biopharma industry. While AI has been widely used in research and development, there is still room for increased integration in downstream commercial operations. Read more to understand how AI biopharma companies will continue to grow and play a pivotal role in enhancing existing capabilities and bolstering pipeline activities. #lifesciences #KPMGHCLS #KPMGDeals
AI and its expanding role across the biopharma landscape
-
Partner, US Deal Advisory and Strategy Leader at KPMG US & Americas Regional Head of Deal Advisory
#Biopharma is embracing the power of #AI. AI is transforming the landscape of the biopharma industry, and our latest paper delves into the key trends and opportunities in this exciting space. KPMG US' latest report, "Artificial intelligence and its expanding role across the biopharma landscape," highlights how AI is no longer confined to research and development but is making waves in downstream commercial operations. This is an exciting era for the biopharma industry, where AI-driven companies are set to revolutionize existing capabilities and bolster pipeline activities. #KPMGDealAdvisory #KPMGHCLS #AIinBiopharma #BiopharmaTrends #ArtificialIntelligence #Innovation #Biopharmaceuticals
AI and its expanding role across the biopharma landscape
kpmg.voicestorm.com
-
I am happy to announce that I have finalized the #AI report that I was working on the past couple of months! In the report you will find the feedback from interviewing 10 senior #biopharma experts on their usage of AI in #drug #discovery and #development (AIDD). Follow the link below if interested to find out more!
How is AI used most frequently in pharma R&D? What ROI have biopharma leaders seen from using AI so far? These are some of the questions Luka Jelcic asked 10 senior biopharma leaders in our latest AI in Drug Discovery and Development (AIDD) Ad Board! This Ad Board covers key themes on the key use cases of AI, unmet needs, ROI seen by leveraging AI approaches, as well as in-depth perceptions of key AI vendors in the space. Interested in learning more? Follow the link to the full report or reach out directly to Luka! AI in Drug Discovery and Development Report: https://lnkd.in/gHej8Ajq #biopharma #AI #drugdiscovery #ROI
Chief Executive Officer at USA and International Research Inc.
2wInnovation is key in drug discovery! Exciting to see Norstella leveraging AI to enhance decision-making and streamline the journey from pipeline to patient.